HSP60 in cancer: a promising biomarker for diagnosis and a potentially useful target for treatment

References

• Wu J, Liu T, Rios Z, et al. Heat Shock Proteins and Cancer. Trends Pharmacol Sci. 2017;38(3):226–256.
   PubMed Web of Science ®Google Scholar
• Kampinga HH, Hageman J, Vos MJ, et al. Guidelines for the nomenclature of the human heat shock proteins. Cell Stress Chaperones. 2009;14(1):105–111.
   PubMed Web of Science ®Google Scholar
• Bepperling A, Alte F, Kriehuber T, et al. Alternative bacterial two-component small heat shock protein systems. Proc Natl Acad Sci USA. 2012;109(50):20407–20412.
   PubMed Web of Science ®Google Scholar
• de Thonel A, Le Mouël A, Mezger V. Transcriptional regulation of small HSP-HSF1 and beyond. Int J Biochem Cell Biol. 2012;44(10):1593–1612.
   PubMed Web of Science ®Google Scholar
• Hansen JJ, Bross P, Westergaard M, et al. Genomic structure of the human mitochondrial chaperonin genes: HSP60 and HSP10 are localised head to head on chromosome 2 separated by a bidirectional promoter. Hum Genet. 2003;112(1):71–77.
   PubMed Web of Science ®Google Scholar
• Parnas A, Nadler M, Nisemblat S, et al. The MitCHAP-60 disease is due to entropic destabilization of the human mitochondrial Hsp60 oligomer. J Biol Chem. 2009;284(41):28198–28203.
   PubMed Web of Science ®Google Scholar
• Ishida R, Okamoto T, Motojima F, et al. Physicochemical properties of the mammalian molecular chaperone HSP60. Int J Mol Sci. 2018;19(2):489.
   Web of Science ®Google Scholar
• Caruso Bavisotto C, Cappello F, Macario A, et al. Exosomal HSP60: a potentially useful biomarker for diagnosis, assessing prognosis, and monitoring response to treatment. Expert Rev Mol Diagn. 2017;17(9):815–822.
   PubMed Web of Science ®Google Scholar
• Campanella C, Bucchieri F, Merendino AM, et al. The odyssey of Hsp60 from tumor cells to other destinations includes plasma membrane-associated stages and Golgi and exosomal protein-trafficking modalities. PLoS One. 2012;7(7):e42008.
   PubMed Web of Science ®Google Scholar
• Gupta S, Knowlton AA. HSP60, Bax, apoptosis and the heart. J Cell Mol Med. 2005;9(1):51–58.
   PubMed Web of Science ®Google Scholar
• Cappello F, Conway de Macario E, Marasa L, et al. Hsp60 expression, new locations, functions and perspectives for cancer diagnosis and therapy. Cancer Biol Ther. 2008;7(6):801–809.
   PubMed Web of Science ®Google Scholar
• Chandra D, Choy G, Tang DG. Cytosolic accumulation of HSP60 during apoptosis with or without apparent mitochondrial release: evidence that its pro-apoptotic or pro-survival functions involve differential interactions with caspase-3. J Biol Chem. 2007;282(43):31289–31301.
   PubMed Web of Science ®Google Scholar
• Tang H, Li J, Liu X, et al. Down-regulation of HSP60 suppresses the proliferation of glioblastoma cells via the ROS/AMPK/mTOR pathway. Sci Rep. 2016;6(1):28388.
   PubMedGoogle Scholar
• Alexiou GA, Vartholomatos G, Stefanaki K, et al. Expression of heat shock proteins in medulloblastoma. J Neurosurg Pediatr. 2013;12(5):452–457.
   PubMed Web of Science ®Google Scholar
• Li XS, Xu Q, Fu XY, et al. Heat shock protein 60 overexpression is associated with the progression and prognosis in gastric cancer. PLoS One. 2014;9(9):e107507.
   PubMed Web of Science ®Google Scholar
• Campanella C, Rappa F, Sciumè C, et al. Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery. Cancer. 2015;121(18):3230–3239.
   PubMed Web of Science ®Google Scholar
• Rappa F, Pitruzzella A, Marino Gammazza A, et al. Quantitative patterns of Hsps in tubular adenoma compared with normal and tumor tissues reveal the value of Hsp10 and Hsp60 in early diagnosis of large bowel cancer. Cell Stress Chaperones. 2016;21(5):927–933.
   PubMed Web of Science ®Google Scholar
• He Y, Wu Y, Mou Z, et al. Proteomics-based identification of HSP60 as a tumor-associated antigen in colorectal cancer. Proteomics Clin Appl. 2007;1(3):336–342.
   PubMed Web of Science ®Google Scholar
• Zhou C, Sun H, Zheng C, et al. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth. Cell Death Dis. 2018;9(2):161.
   PubMedGoogle Scholar
• Chant ID, Rose PE, Morris AG. Analysis of heat-shock protein expression in myeloid leukaemia cells by flow cytometry. Br J Haematol. 1995;90(1):163–168.
   PubMed Web of Science ®Google Scholar
• Wu X, Guo J, Chen Y, et al. The 60-kDa heat shock protein regulates energy rearrangement and protein synthesis to promote proliferation of multiple myeloma cells [published online ahead of print, 2020 Mar 10]. Br J Haematol. 2020;190(5):741–752. https://doi.org/10.1111/bjh.16569.
   PubMed Web of Science ®Google Scholar
• Chen FM, Huang LJ, Ou-Yang F, et al. Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer. Breast Cancer Res Treat. 2020;183(1):61–70.
   PubMed Web of Science ®Google Scholar
• Desmetz C, Bibeau F, Boissière F, et al. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. J Proteome Res. 2008;7(9):3830–3837.
   PubMed Web of Science ®Google Scholar
• Li DQ, Wang L, Fei F, et al. Identification of breast cancer metastasis-associated proteins in an isogenic tumor metastasis model using two-dimensional gel electrophoresis and liquid chromatography-ion trap-mass spectrometry. Proteomics. 2006;6(11):3352–3368.
   PubMed Web of Science ®Google Scholar
• Hwang YJ, Lee SP, Kim SY, et al. Expression of heat shock protein 60 kDa is upregulated in cervical cancer. Yonsei Med J. 2009;50(3):399–406.
   PubMed Web of Science ®Google Scholar
• Guo J, Li X, Zhang W, et al. HSP60-regulated mitochondrial proteostasis and protein translation promote tumor growth of ovarian cancer. Sci Rep. 2019;9(1):12628.
   PubMedGoogle Scholar
• Castilla C, Congregado B, Conde JM, et al. Immunohistochemical Expression of Hsp60 Correlates With Tumor Progression and Hormone Resistance in Prostate Cancer. Urology. 2010; 76(4):1017.e1–e6.
   Web of Science ®Google Scholar
• Lu L, Zhang J, Gan P, et al. Novel functions of CD147 in the mitochondria exacerbates melanoma metastasis. Int J Biol Sci. 2021;17(1):285–297.
   PubMed Web of Science ®Google Scholar
• Cappello F, Di Stefano A, David S, et al. Hsp60 and Hsp10 down-regulation predicts bronchial epithelial carcinogenesis in smokers with chronic obstructive pulmonary disease. Cancer. 2006;107(10):2417–2424.
   PubMed Web of Science ®Google Scholar
• Cappello F, Di Stefano A, D’Anna SE, et al. Immunopositivity of heat shock protein 60 as a biomarker of bronchial carcinogenesis. Lancet Oncol. 2005;6(10):816.
   PubMed Web of Science ®Google Scholar
• Teng R, Liu Z, Tang H, et al. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells. Redox Biol. 2019;24:101218.
   PubMed Web of Science ®Google Scholar
• Tang H, Chen Y, Liu X, et al. Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma. Oncotarget 2016;7(25):38822–38834.
   PubMedGoogle Scholar
• Lebret T, Watson RW, Molinie V, et al. Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma. Cancer 2003;98(5):970–977.
   PubMedGoogle Scholar
• Mittal S, Rajala MS. Heat shock proteins as biomarkers of lung cancer. Cancer Biol Ther. 2020;21(6):477–485.
   PubMed Web of Science ®Google Scholar
• Huang YH, Lin KH, Yu JS, et al. Targeting HSP60 by subcutaneous injections of jetPEI/HSP60-shRNA destabilizes cytoplasmic survivin and inhibits hepatocellular carcinoma growth. Mol Carcinog. 2018;57(9):1087–1101.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhou X, Chang H, et al. Hsp60 exerts a tumor suppressor function by inducing cell differentiation and inhibiting invasion in hepatocellular carcinoma. Oncotarget 2016;7(42):68976–68989.
   PubMedGoogle Scholar
• Tsai YP, Yang MH, Huang CH, et al. Interaction between HSP60 and beta-catenin promotes metastasis. Carcinogenesis 2009;30(6):1049–1057.
   PubMed Web of Science ®Google Scholar
• Thomas X, Campos L, Mounier C, et al. Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia. Leuk Res. 2005;29(9):1049–1058.
   PubMed Web of Science ®Google Scholar
• Duval A, Olaru D, Campos L, et al. Expression and prognostic significance of heat-shock proteins in myelodysplastic syndromes. Haematologica. 2006;91(5):713–714.
   PubMed Web of Science ®Google Scholar
• Merendino AM, Bucchieri F, Campanella C, et al. Hsp60 is actively secreted by human tumor cells. PLoS One. 2010;5(2):e9247.
   PubMed Web of Science ®Google Scholar
• Ghosh JC, Dohi T, Kang BH, et al. Hsp60 regulation of tumor cell apoptosis. J Biol Chem. 2008;283(8):5188–5194.
   PubMed Web of Science ®Google Scholar
• Ghosh JC, Siegelin MD, Dohi T, et al. Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res. 2010;70(22):8988–8993.
   PubMed Web of Science ®Google Scholar
• Shan YX, Liu TJ, Su HF, et al. Hsp10 and Hsp60 modulate Bcl-2 family and mitochondria apoptosis signaling induced by doxorubicin in cardiac muscle cells. J Mol Cell Cardiol. 2003;35(9):1135–1143.
   PubMed Web of Science ®Google Scholar
• Kao TY, Chiu YC, Fang WC, et al. Mitochondrial Lon regulates apoptosis through the association with Hsp60-mtHsp70 complex. Cell Death Dis. 2015;6:e1642.
   PubMed Web of Science ®Google Scholar
• Veereshwarayya V, Kumar P, Rosen KM, et al. Differential effects of mitochondrial heat shock protein 60 and related molecular chaperones to prevent intracellular beta-amyloid-induced inhibition of complex IV and limit apoptosis. J Biol Chem. 2006;281(40):29468–29478.
   PubMed Web of Science ®Google Scholar
• Kol A, Lichtman AH, Finberg RW, et al. Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells. J Immunol. 2000;164(1):13–17.
   PubMed Web of Science ®Google Scholar
• Binder RJ, Vatner R, Srivastava P. The heat-shock protein receptors: some answers and more questions. Tissue Antigens. 2004; 64(4):442–451.
   PubMedGoogle Scholar
• Heiserman JP, Chen L, Kim BS, et al. TLR4 mutation and HSP60-induced cell death in adult mouse cardiac myocytes. Cell Stress Chaperones. 2015;20(3):527–535.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang R, Hou X, et al. Microglia activation triggers oligodendrocyte precursor cells apoptosis via HSP60. Mol Med Rep. 2017;16(1):603–608.
   PubMed Web of Science ®Google Scholar
• Swaroop S, Mahadevan A, Shankar SK, et al. HSP60 critically regulates endogenous IL-1β production in activated microglia by stimulating NLRP3 inflammasome pathway. J Neuroinflammation. 2018;15(1):177.
   PubMedGoogle Scholar
• Kim SC, Stice JP, Chen L, et al. Extracellular heat shock protein 60, cardiac myocytes, and apoptosis. Circ Res. 2009;105(12):1186–1195.
   PubMed Web of Science ®Google Scholar
• Samali A, Cai J, Zhivotovsky B, et al. Presence of a pre-apoptotic complex of pro-caspase-3, Hsp60 and Hsp10 in the mitochondrial fraction of jurkat cells. EMBO J. 1999;18(8):2040–2048.
   PubMed Web of Science ®Google Scholar
• Xanthoudakis S, Roy S, Rasper D, et al. Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J. 1999;18(8):2049–2056.
   PubMed Web of Science ®Google Scholar
• Alard J-E, Dueymes M, Youinou P, et al. Modulation of endothelial cell damages by anti-Hsp60 autoantibodies in systemic autoimmune diseases. Autoimmun Rev. 2007;6(7):438–443.
   PubMed Web of Science ®Google Scholar
• Slot MC, Theunissen R, van Paassen P, et al. Evaluation of antibodies against human HSP60 in patients with MPO-ANCA associated glomerulonephritis: a cohort study. J Autoimmune Dis. 2006;3:4.
   PubMedGoogle Scholar
• Alard JE, Dueymes M, Youinou P, et al. HSP60 and anti-HSP60 antibodies in vasculitis: they are two of a kind. Clinic Rev Allerg Immunol. 2008;35(1–2):66–71.
   PubMed Web of Science ®Google Scholar
• Caruso Bavisotto C, Marino Gammazza A, Lo Cascio F, et al. Curcumin affects HSP60 folding activity and levels in neuroblastoma cells. Int J Mol Sci. 2020;21(2):661.
   Web of Science ®Google Scholar
• Kim W, Ryu J, Kim JE. CCAR2/DBC1 and Hsp60 positively regulate expression of survivin in neuroblastoma cells. Int J Mol Sci. 2019;20(1):131.
   Web of Science ®Google Scholar
• Singh P, Kumari M, Bal A, et al. Heat shock protein 60 is a disease-associated sialoglycoprotein in human non-small cell lung cancer. Biol Chem. 2020;401(8):969–983.
   PubMed Web of Science ®Google Scholar
• Tang Y, Yang Y, Luo J, et al. Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients. Cancer Biomark. 2021;30(1):85–94.
   PubMed Web of Science ®Google Scholar
• Faried A, Sohda M, Nakajima M, et al. Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. Eur J Cancer. 2004;40(18):2804–2811.
   PubMed Web of Science ®Google Scholar
• Slotta-Huspenina J, Wolff C, Drecoll E, et al. A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas. Br J Cancer. 2013;109(2):370–378.
   PubMed Web of Science ®Google Scholar
• Vocka M, Langer D, Fryba V, et al. Novel serum markers HSP60, CHI3L1, and IGFBP-2 in metastatic colorectal cancer. Oncol Lett. 2019;18(6):6284–6292.
   PubMed Web of Science ®Google Scholar
• Hamelin C, Cornut E, Poirier F, et al. Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer. FEBS J. 2011;278(24):4845–4859.
   PubMed Web of Science ®Google Scholar
• Spisak S, Galamb B, Sipos F, et al. Applicability of antibody and mRNA expression microarrays for identifying diagnostic and progression markers of early and late stage colorectal cancer. Dis Markers. 2010;28(1):1–14.
   PubMed Web of Science ®Google Scholar
• Urushibara M, Kageyama Y, Akashi T, et al. HSP60 may predict good pathological response to neoadjuvant chemoradiotherapy in bladder cancer. Jpn J Clin Oncol. 2007;37(1):56–61.
   PubMed Web of Science ®Google Scholar
• Mano R, Zilber S, Di NR, et al. Heat shock proteins 60 and 70 are associated with long-term outcome of T1-stage high-grade urothelial tumors of the bladder treated with intravesical Bacillus Calmette-Guerin immunotherapy. Urol Oncol. 2018;36(12):531 e9–e17.
   Web of Science ®Google Scholar
• Sedlackova L, Spacek M, Holler E, et al. Heat-shock protein expression in leukemia. Tumour Biol. 2011;32(1):33–44.
   PubMedGoogle Scholar
• Hamrita B, Chahed K, Kabbage M, et al. Identification of tumor antigens that elicit a humoral immune response in breast cancer patients' sera by serological proteome analysis (SERPA). Clin Chim Acta. 2008;393(2):95–102.
   PubMed Web of Science ®Google Scholar
• Caruso Bavisotto C, Cipolla C, Graceffa G, et al. Immunomorphological pattern of molecular chaperones in normal and pathological thyroid tissues and circulating exosomes: potential use in clinics. Int J Mol Sci. 2019;20(18):4496.
   Web of Science ®Google Scholar
• Marino Gammazza A, Campanella C, Barone R, et al. Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60/p53 complex dissociation and instauration of replicative senescence. Cancer Lett. 2017;385:75–86.
   PubMed Web of Science ®Google Scholar
• Caruso Bavisotto C, Nikolic D, Marino Gammazza A, et al. The dissociation of the Hsp60/pro-Caspase-3 complex by bis(pyridyl)oxadiazole copper complex (CubipyOXA) leads to cell death in NCI-H292 cancer cells. J Inorg Biochem. 2017;170:8–16.
   PubMed Web of Science ®Google Scholar
• Campanella C, D'Anneo A, Marino Gammazza A, et al. The histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells. Oncotarget 2016;7(20):28849–28867.
   PubMedGoogle Scholar
• Wang S, Li L, Ning X, et al. pH-activated heat shock protein inhibition and radical generation enhanced NIR luminescence imaging-guided photothermal tumour ablation. Int J Pharm. 2019;566:40–45.
   PubMedGoogle Scholar
• Gorska M, Marino Gammazza A, Zmijewski MA, et al. Geldanamycin-induced osteosarcoma cell death is associated with hyperacetylation and loss of mitochondrial pool of heat shock protein 60 (hsp60). PLoS One. 2013;8(8):e71135.
   PubMed Web of Science ®Google Scholar
• Gong X, Smith JR, Swanson HM, et al. Carotenoid lutein selectively inhibits breast cancer cell growth and potentiates the effect of chemotherapeutic agents through ROS-mediated mechanisms. Molecules 2018;23(4):905.
   Web of Science ®Google Scholar
• Arya RK, Singh A, Yadav NK, et al. Anti-breast tumor activity of Eclipta extract in-vitro and in-vivo: novel evidence of endoplasmic reticulum specific localization of Hsp60 during apoptosis. Sci Rep. 2015;5:18457.
   PubMed Web of Science ®Google Scholar
• Chang CL, Hsu YT, Wu CC, et al. Immune mechanism of the antitumor effects generated by bortezomib. J Immunol. 2012;189(6):3209–3220.
   PubMed Web of Science ®Google Scholar
• Fucarino A, Pitruzzella A. Role of HSP60/HSP10 in lung cancer: simple biomarkers or leading actors? J Oncol. 2020;2020:4701868.
   PubMed Web of Science ®Google Scholar
• Lu W, Wang Y, Gan M, et al. Prognosis and predictive value of heat-shock proteins expression in oral cancer: A PRISMA-compliant meta-analysis. Medicine 2021;100(3):e24274.
   PubMed Web of Science ®Google Scholar
• Cappello F, David S, Peri G, et al. Hsp60: molecular anatomy and role in colorectal cancer diagnosis and treatment. Front Biosci 2011;3:341–351.
   Google Scholar
• Ruan W, Wang Y, Ma Y, et al. HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma. J Exp Clin Cancer Res. 2010;29:41.
   PubMed Web of Science ®Google Scholar
• Hoter A, Rizk S, Naim HY. Heat shock protein 60 in hepatocellular carcinoma: insights and perspectives. Front Mol Biosci. 2020;7:60.
   PubMed Web of Science ®Google Scholar
• Emura I, Chou T, Imai Y, et al. Overexpression of heat shock protein 60 and the survival of blast in acute myeloid leukemia after induction therapy. Leukemia 2000;14(8):1529–1530.
   PubMed Web of Science ®Google Scholar
• Haaland I, Opsahl JA, Berven FS, et al. Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemia. Mol Cancer. 2014;13:116.
   PubMed Web of Science ®Google Scholar
• Chalmers SA, Eidelman AS, Ewer JC, et al. A role for HMGB1, HSP60 and Myd88 in growth of murine mammary carcinoma in vitro. Cell Immunol. 2013;282(2):136–145.
   PubMed Web of Science ®Google Scholar
• Choghaei E, Khamisipour G, Falahati M, et al. Knockdown of microRNA-29a changes the expression of heat shock proteins in breast carcinoma MCF-7 cells. Oncol Res. 2016;23(1):69–78.
   Web of Science ®Google Scholar
• Kimura E, Enns RE, Thiebaut F, et al. Regulation of HSP60 mRNA expression in a human ovarian carcinoma cell line. Cancer Chemother Pharmacol. 1993;32(4):279–285.
   PubMed Web of Science ®Google Scholar
• Hoter A, Rizk S, Naim HY. The multiple roles and therapeutic potential of molecular chaperones in prostate cancer. Cancers 2019;11(8):1194.
   Web of Science ®Google Scholar
• Chaudhary AK, Bhat TA, Kumar S, et al. Mitochondrial dysfunction-mediated apoptosis resistance associates with defective heat shock protein response in African-American men with prostate cancer. Br J Cancer. 2016;114(10):1090–1100.
   PubMed Web of Science ®Google Scholar
• Abu-Hadid M, Wilkes JD, Elakawi Z, et al. Relationship between heat shock protein 60 (HSP60) mRNA expression and resistance to platinum analogues in human ovarian and bladder carcinoma cell lines. Cancer Lett. 1997;119(1):63–70.
   PubMed Web of Science ®Google Scholar
• Castagna A, Antonioli P, Astner H, et al. A proteomic approach to cisplatin resistance in the cervix squamous cell carcinoma cell line A431. Proteomics 2004;4(10):3246–3267.
   PubMed Web of Science ®Google Scholar
• Shen D, Akiyama S, Schoenlein P, et al. Characterisation of high-level cisplatin-resistant cell lines established from a human hepatoma cell line and human KB adenocarcinoma cells: cross-resistance and protein changes. Br J Cancer. 1995;71(4):676–683.
   PubMed Web of Science ®Google Scholar
• Kumar S, O’Malley J, Chaudhary AK, et al. Hsp60 and IL-8 axis promotes apoptosis resistance in cancer. Br J Cancer. 2019;121(11):934–943.
   PubMed Web of Science ®Google Scholar
• Caruso Bavisotto C, Graziano F, Rappa F, et al. Exosomal chaperones and miRNAs in gliomagenesis: state-of-art and theranostics perspectives. Int J Mol Sci. 2018;19(9):2626.
   Web of Science ®Google Scholar
• Zhong H, Yang Y, Ma S, et al. Induction of a tumour-specific CTL response by exosomes isolated from heat-treated malignant ascites of gastric cancer patients. Int J Hyperthermia. 2011;27(6):604–611.
   PubMed Web of Science ®Google Scholar
• Lv LH, Wan YL, Lin Y, et al. Anticancer drugs cause release of exosomes with heat shock proteins from human hepatocellular carcinoma cells that elicit effective natural killer cell antitumor responses in vitro. J Biol Chem. 2012;287(19):15874–15885.
   PubMed Web of Science ®Google Scholar
• Chen W, Wang J, Shao C, et al. Efficient induction of antitumor T cell immunity by exosomes derived from heat-shocked lymphoma cells. Eur J Immunol. 2006;36(6):1598–1607.
   PubMed Web of Science ®Google Scholar
• Stefano F, Mariantonia L, Giusi A, et al. Exosomal Hsp60: a tumor biomarker. In: Alexzander AA, Asea PK, editors. Heat shock protein 60 in human diseases and disorders. Switzerland: Springer; 2019. p. 107–116.
   Google Scholar